Abstract

BackgroundSystemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by autoantibody production, complement activation and deposition of immune complexes in tissues and organs. According to different authors about 25–79%...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors
A Orozco-Narvaez ... Y Richaud-Patin
Rheumatology | VOL. 48
A Orozco-Narvaez, et. al.A Orozco-Narvaez ... Y Richaud-Patin
15 Sep 2009
AB0432 Overlapping neuropsychiatric manifestations in patients with systemic lupus erythematosus
S V Monov ... R K Rashkov
Annals of the Rheumatic Diseases | VOL. 72
S V Monov, et. al.S V Monov ... R K Rashkov
01 Jun 2013
Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia.
Chung-Hsiang Liu ... Chon-Haw Tsai
Acta neurologica Taiwanica | VOL. 16
Chung-Hsiang Liu, et. al.Chung-Hsiang Liu ... Chon-Haw Tsai
01 Jun 2007
P141 Occurrence of neuropsychiatric manifestations in patients with systemic lupus erythematosus: results from the swiss lupus cohort and meta-analysis of the pertinent literature
Aline Meier ... Lucas M Bachmann
Lupus Science & Medicine | VOL. 7
Aline Meier, et. al.Aline Meier ... Lucas M Bachmann
01 Mar 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers